Physician profile
Calli Berman
NPI 1609363431
$2,182.51
in general payments reported to CMS, 2019-2025
17 companies · $597 in 2025
The $597 reported for 2025 was more than what 76% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $358 · 2022: $439 · 2023: $393 · 2024: $395 · 2025: $597.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,386.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,385.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $814.88 | 2021-2025 | |
| Indivior INC. | $312.60 | 2022-2025 | Sublocade |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $165.54 | 2025 | Caplyta |
| Astrazeneca Pharmaceuticals LP | $125.18 | 2022 | |
| Braeburn INC. | $122.37 | 2023-2025 | Brixadi |
| Alexion Pharmaceuticals, INC. | $107.10 | 2022 | |
| Orexo US, INC. | $88.46 | 2021-2025 | Zubsolv |
| Alkermes, INC. | $88.36 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $68.98 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $65.10 | 2021-2022 | |
| Lundbeck LLC | $56.39 | 2022-2023 | Rexulti |
| Pfizer INC. | $55.37 | 2023-2024 | |
| Otsuka America Pharmaceutical, INC. | $42.82 | 2025 | Rexulti |
| Hologic Sales and Service, LLC | $19.05 | 2024 | Aptima |
| Uswm, LLC | $17.76 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $16.31 | 2025 | Auvelity |
| Gilead Sciences, INC. | $16.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Calli Berman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.